EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics

Jianhong Liao, Hong Pan, Guojun Huang, Han Gong, Ze Chen, Ting Yin, Baozhen Zhang, Tingtao Chen, Mingbin Zheng, Lintao Cai

Cell Reports · 2024-04 · 43 (4) · 114086

DOI: 10.1016/j.celrep.2024.114086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-04. Verfasst von Jianhong Liao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, CAS Key Laboratory of Biomedical Imaging Science and System, Institute of…. Hauptthemen laut MEDLINE: Interleukin-12, Probiotics, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-12ProbioticsProgrammed Cell Death 1 ReceptorAnimalsMiceImmune Checkpoint InhibitorsHumansMice, Inbred C57BLCell Line, TumorT-LymphocytesCD8-Positive T-LymphocytesEscherichia coliNeoplasmsNanoparticlesFemaleLymphocyte Activation

Stichwörter der Autor:innen

CP: Canceranti-PD-1engineered probioticsimmune cascade regulationinterleukin-12living drug factory

Substanzen

Interleukin-12Programmed Cell Death 1 ReceptorImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, CAS Key Laboratory of Biomedical Imaging Science and System, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technol…
  • National Engineering Research Center for Bioengineering Drugs and the Technologies, Institute of Translational Medicine, Nanchang University, Nanchang 330031, China. Electronic address: chentingtao1984@163.com.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Chinese Academy of Sciences Shenzhen Institutes of Advanced Technology
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Natural Science Foundation of Guangdong Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Liao, J., Pan, H., Huang, G., Gong, H., Chen, Z., Yin, T., Zhang, B., Chen, T., Zheng, M., & Cai, L. (2024). T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics. Cell Reports, 43(4), 114086. https://doi.org/10.1016/j.celrep.2024.114086

Vancouver

Liao J, Pan H, Huang G, Gong H, Chen Z, Yin T, et al. T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics. Cell Reports. 2024;43(4):114086. doi:10.1016/j.celrep.2024.114086

BibTeX
@article{Liao2024,
  author = {Liao, Jianhong and Pan, Hong and Huang, Guojun and Gong, Han and Chen, Ze and Yin, Ting and Zhang, Baozhen and Chen, Tingtao and Zheng, Mingbin and Cai, Lintao},
  title = {T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1/IL-12 engineered probiotics},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {4},
  pages = {114086},
  doi = {10.1016/j.celrep.2024.114086}
}
Kostenlos starten →